Clinical Trial Update: A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 dose-escalation study evaluating long-acting ACTH gel in membranous nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Membranous Nephropathy

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Glomerulonephritis | Phase 1, Phase 2 | Status: COMPLETED